Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...

The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that recent use of a year or more ...

Between condoms and vasectomies lies a vast, undeveloped chasm of male birth control. Contraline, a device startup that released early, positive clinical data in a press release on Thursday, hopes to ...

When it comes to their sexual health, what women don’t know can hurt them. But University Health Center officials are trying to help women improve their health by educating them about birth control ...

Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...